Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2020 · 10-Q
Revenue$38.00K$38.00K−82.4% vs Q1 2019 Net Income-$4.59M-$4.59MN/M vs Q1 2019 EPS Diluted-$0.67-$0.67N/M vs Q1 2019 Operating Income-$4,609,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,998,000N/M Margins · derivedOperating margin-12128.9%−10422.0 pt vs Q1 2019
Net margin-12089.5%−10392.7 pt vs Q1 2019
ended Mar 31, 2020 · filed May 15, 2020 · 45 d after period end